Register for email alerts and news feeds:
This journal | BMJ Group
rss
Molecular Pathology 2001;54:176-179; doi:10.1136/mp.54.3.176
Copyright © 2001 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
J Clin Pathol: Mol Pathol 2001; 54:176-179
© 2001 Journal of Clinical Pathology

Regulation of connective tissue growth factor (ccn2*; ctgf) gene expression in human mesangial cells: modulation by HMG CoA reductase inhibitors (statins)

M Goppelt-Struebe1, A Hahn1, D Iwanciw1, M Rehm1 and B Banas2

1 Medizinische Klinik IV, Universität Erlangen-Nürnberg, Loschgestrasse 8, D-91054 Erlangen, Germany
2 Medizinische Poliklinik, Ludwig-Maximilians-Universität München, Pettenkoferstrasse 8a, 80336 München, Germany

Correspondence to:
Professor Goppelt-Struebe Goppelt-Struebe{at}rzmail.uni-erlangen.de

Aim—Connective tissue growth factor (ccn; ctgf) gene expression is upregulated in fibrotic renal glomeruli. Therefore, the regulation and pharmacological modulation of ccn2 (ctgf) mRNA expression was investigated in a human renal mesangial cell line.

Methods—A human renal mesangial cell line was cultured in vitro under standard conditions. After stimulation, RNA was extracted and ccn2 (ctgf) mRNA expression assessed by northern blot analysis.

Results—The expression of ccn2 (ctgf) mRNA was transiently upregulated by fetal calf serum. Very rapid onset but short lasting ccn2 (ctgf) mRNA expression was observed after stimulation with lysophosphatidic acid, a bioactive lipid, which activates G protein coupled receptors. Induction of ccn2 (ctgf) mRNA expression by transforming growth factor ß (TGF-ß) was more prolonged and lasted for more than one day. The small GTPases of the Rho family were essential for basal as well as induced ccn2 (ctgf) expression: preincubation of the cells with toxin B from Clostridium difficile abrogated ccn2 (ctgf) mRNA expression. HMG CoA reductase inhibitors, which are therapeutically used as lipid lowering drugs, interfere with the isoprenylation and thus activation of Rho proteins. Simvastatin, an HMG CoA reductase inhibitor, inhibited ccn2 (ctgf) mRNA expression in a concentration dependent manner (IC50: 1–2 µM).

Conclusion—Statins were identified as potent inhibitors of ccn2 (ctgf) mRNA expression in mesangial cells, and therefore might be of potential use to modulate the excessive ccn2 (ctgf) expression in mesangial cells related to glomerular fibrosis.

Key Words: connective tissue growth factor • ccn2 • Rho proteins • statins • mesangial cells


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Black, S. A. Jr., Trackman, P. C. (2008). Transforming Growth Factor-{beta}1 (TGF{beta}1) Stimulates Connective Tissue Growth Factor (CCN2/CTGF) Expression in Human Gingival Fibroblasts through a RhoA-independent, Rac1/Cdc42-dependent Mechanism: STATINS WITH FORSKOLIN BLOCK TGF{beta}1-INDUCED CCN2/CTGF EXPRESSION. J. Biol. Chem. 283: 10835-10847 [Abstract] [Full Text]  
  • Harlow, C. R, Bradshaw, A. C, Rae, M. T, Shearer, K. D, Hillier, S. G (2007). Oestrogen formation and connective tissue growth factor expression in rat granulosa cells. J Endocrinol 192: 41-52 [Abstract] [Full Text]  
  • Watts, K. L., Sampson, E. M., Schultz, G. S., Spiteri, M. A. (2005). Simvastatin Inhibits Growth Factor Expression and Modulates Profibrogenic Markers in Lung Fibroblasts. Am. J. Respir. Cell Mol. Bio. 32: 290-300 [Abstract] [Full Text]  
  • Schrijvers, B. F., De Vriese, A. S., Flyvbjerg, A. (2004). From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines. Endocr. Rev. 25: 971-1010 [Abstract] [Full Text]  
  • Watts, K. L., Spiteri, M. A. (2004). Connective tissue growth factor expression and induction by transforming growth factor-{beta} is abrogated by simvastatin via a Rho signaling mechanism. Am. J. Physiol. Lung Cell. Mol. Physiol. 287: L1323-L1332 [Abstract] [Full Text]  
  • Trackman, P. C., Kantarci, A. (2004). CONNECTIVE TISSUE METABOLISM AND GINGIVAL OVERGROWTH. CROBM 15: 165-175 [Abstract] [Full Text]  
  • Twigg, S. M., Cao, Z., MCLennan, S. V., Burns, W. C., Brammar, G., Forbes, J. M., Cooper, M. E. (2002). Renal Connective Tissue Growth Factor Induction in Experimental Diabetes Is Prevented by Aminoguanidine. Endocrinology 143: 4907-4915 [Abstract] [Full Text]  
  • Harlow, C. R., Davidson, L., Burns, K. H., Yan, C., Matzuk, M. M., Hillier, S. G. (2002). FSH and TGF-{beta} Superfamily Members Regulate Granulosa Cell Connective Tissue Growth Factor Gene Expression in Vitro and in Vivo. Endocrinology 143: 3316-3325 [Abstract] [Full Text]  

Pathology jobs

Pathology jobs